Compare LATA & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LATA | DERM |
|---|---|---|
| Founded | 2025 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 229.1M | 257.1M |
| IPO Year | 2025 | 2021 |
| Metric | LATA | DERM |
|---|---|---|
| Price | $10.08 | $7.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $12.67 |
| AVG Volume (30 Days) | 56.6K | ★ 128.6K |
| Earning Date | 01-01-0001 | 03-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $59,399,000.00 |
| Revenue This Year | N/A | $17.48 |
| Revenue Next Year | N/A | $55.83 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 2.82 |
| 52 Week Low | $9.92 | $4.85 |
| 52 Week High | $10.20 | $9.56 |
| Indicator | LATA | DERM |
|---|---|---|
| Relative Strength Index (RSI) | 58.96 | 41.29 |
| Support Level | $10.02 | $7.57 |
| Resistance Level | $10.13 | $8.29 |
| Average True Range (ATR) | 0.01 | 0.45 |
| MACD | 0.01 | -0.11 |
| Stochastic Oscillator | 73.68 | 17.02 |
Galata Acquisition Corp II is a blank check company.
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.